Works matching AU Thall, Peter F

Results: 125

A decision-theoretic phase I-II design for ordinal outcomes in two cycles.

Published in:

2016

By:

JUHEE LEE;
PETER F. THALL;
YUAN JI;
MÜLLER, PETER;
Lee, Juhee;
Thall, Peter F;
Ji, Yuan;
Müller, Peter

Publication type:

journal article

A phase I-II design based on periodic and continuous monitoring of disease status and the times to toxicity and death.

Published in:

2020

By:

Lee, Juhee;
F. Thall, Peter;
Msaouel, Pavlos;
F Thall, Peter

Publication type:

journal article

Atypical choroid plexus papilloma: clinical experience in the CPT-SIOP-2000 study.

Published in:

Journal of Neuro-Oncology, 2009, v. 95, n. 3, p. 383, doi. 10.1007/s11060-009-9936-y

By:

Wrede, Brigitte;
Hasselblatt, Martin;
Peters, Ove;
Thall, Peter F.;
Kutluk, Tezer;
Moghrabi, Albert;
Mahajan, Anita;
Rutkowski, Stefan;
Diez, Blanca;
Xuemei Wang;
Pietsch, Torsten;
Kortmann, Rolf-Dieter;
Paulus, Werner;
Jeibmann, Astrid;
Wolff, Johannes E. A.

Publication type:

Article

A review of phase 2-3 clinical trial designs.

Published in:

2008

By:

Thall PF;
Thall, Peter F

Publication type:

journal article

Serum Cytokine Levels in Infectious Mononucleosis at Diagnosis and Convalescence.

Published in:

Leukemia & Lymphoma, 1998, v. 30, n. 5/6, p. 583, doi. 10.3109/10428199809057570

By:

Wright-Browne, Vance;
Schnee, Amanda M.;
Jenkins, Mark A.;
Thall, Peter F.;
Aggarwal, Bharat B.;
Talpaz, Moshe;
Estrov, Zeev

Publication type:

Article

Bayesian sequential monitoring designs for single-arm clinical trials with multiple outcomes.

Published in:

1995

By:

Thall, Peter F.;
Simon, Richard M.;
Estey, Elihu H.;
Thall, P F;
Simon, R M;
Estey, E H

Publication type:

journal article

An optimal three-stage design for phase II clinical trials.

Published in:

1994

By:

Ensign, Lisa Garnsey;
Gehan, Edmund A.;
Kamen, Douglas S.;
Thall, Peter F.;
Ensign, L G;
Gehan, E A;
Kamen, D S;
Thall, P F

Publication type:

journal article

A bayesian strategy for screening cancer treatments prior to phase ii clinical evaluation.

Published in:

Statistics in Medicine, 1993, v. 12, n. 13, p. 1197, doi. 10.1002/sim.4780121303

By:

Thall, Peter F.;
Estey, Elihu H.

Publication type:

Article

A bayesian strategy for screening cancer treatments prior to phase ii clinical evaluation.

Published in:

Statistics in Medicine, 1993, v. 12, n. 11, p. 1197, doi. 10.1002/sim.4780121103

By:

Thall, Peter F.;
Estey, Elihu H.

Publication type:

Article

Incorporating historical control data in planning phase II clinical trials.

Published in:

Statistics in Medicine, 1990, v. 9, n. 3, p. 215, doi. 10.1002/sim.4780090304

By:

Thall, Peter F.;
Simon, Richard

Publication type:

Article

Optimal two-stage designs for clinical trials with binary response.

Published in:

Statistics in Medicine, 1988, v. 7, n. 5, p. 571, doi. 10.1002/sim.4780070504

By:

Thall, Peter F.;
Simon, Richard;
Ellenberg, Susan S.;
Shrager, Richard

Publication type:

Article

Assessment of stratum-covariate interactions in Cox's proportional hazards regression model.

Published in:

1986

By:

Thall, Peter F.;
Lachin, John M.;
Thall, P F;
Lachin, J M

Publication type:

journal article

Signet ring cells and conditional survival after trimodality therapy for esophageal adenocarcinoma.

Published in:

Journal of Surgical Oncology, 2024, v. 130, n. 3, p. 428, doi. 10.1002/jso.27774

By:

Mitchell, Kyle G.;
Feldman, Hope;
Milton, Denái R.;
Antonoff, Mara B.;
Hofstetter, Wayne L.;
Rice, David C.;
Vaporciyan, Ara A.;
Lin, Ruitao;
Thall, Peter F.;
Rajaram, Ravi

Publication type:

Article

Analysis of Recurrent Events: Nonparametric Methods for Random-Interval Count Data.

Published in:

Journal of the American Statistical Association, 1988, v. 83, n. 402, p. 339, doi. 10.1080/01621459.1988.10478603

By:

Thall, Peter F.;
Lachin, John M.

Publication type:

Article

Stochastic Processes (Book).

Published in:

1979

By:

Thall, Peter F.

Publication type:

Book Review

Huber-Sense Robust M-Estimation of a Scale Parameter, with Application to the Exponential Distribution.

Published in:

Journal of the American Statistical Association, 1979, v. 74, n. 365, p. 147, doi. 10.1080/01621459.1979.10481631

By:

Thall, Peter F.

Publication type:

Article

Generalized phase I‐II designs to increase long term therapeutic success rate.

Published in:

Pharmaceutical Statistics, 2023, v. 22, n. 4, p. 692, doi. 10.1002/pst.2301

By:

Thall, Peter F.;
Zang, Yong;
Yuan, Ying

Publication type:

Article

A Bayesian piecewise exponential phase II design for monitoring a time‐to‐event endpoint.

Published in:

Pharmaceutical Statistics, 2023, v. 22, n. 1, p. 34, doi. 10.1002/pst.2256

By:

Qing, Yun;
Thall, Peter F.;
Yuan, Ying

Publication type:

Article

Comparing Bayesian early stopping boundaries for phase II clinical trials.

Published in:

Pharmaceutical Statistics, 2020, v. 19, n. 6, p. 928, doi. 10.1002/pst.2046

By:

Jiang, Liyun;
Yan, Fangrong;
Thall, Peter F.;
Huang, Xuelin

Publication type:

Article

Subgroup‐specific dose finding in phase I clinical trials based on time to toxicity allowing adaptive subgroup combination.

Published in:

Pharmaceutical Statistics, 2018, v. 17, n. 6, p. 734, doi. 10.1002/pst.1891

By:

Chapple, Andrew G.;
Thall, Peter F.

Publication type:

Article

Bayesian nonparametric statistics: A new toolkit for discovery in cancer research.

Published in:

Pharmaceutical Statistics, 2017, v. 16, n. 6, p. 414, doi. 10.1002/pst.1819

By:

Thall, Peter F.;
Mueller, Peter;
Xu, Yanxun;
Guindani, Michele

Publication type:

Article

A simulation study of methods for selecting subgroup-specific doses in phase 1 trials.

Published in:

Pharmaceutical Statistics, 2017, v. 16, n. 2, p. 143, doi. 10.1002/pst.1797

By:

Morita, Satoshi;
Thall, Peter F.;
Takeda, Kentaro

Publication type:

Article

Approximate Bayesian Evaluation of Multiple Treatment Effects.

Published in:

Biometrics, 2000, v. 56, n. 1, p. 213, doi. 10.1111/j.0006-341X.2000.00213.x

By:

Thall, Peter F.;
Simon, Richard M.;
Shen, Yu

Publication type:

Article

Treatment Comparisons Based on Two-Dimensional Safety and Efficacy Alternatives in Oncology Trials.

Published in:

Biometrics, 1999, v. 55, n. 3, p. 746, doi. 10.1111/j.0006-341X.1999.00746.x

By:

Thall, Peter F.;
Chengt, Su-Chun

Publication type:

Article

Decision Theoretic Designs for Phase II Clinical Trials with Multiple Outcomes.

Published in:

Biometrics, 1999, v. 55, n. 3, p. 971, doi. 10.1111/j.0006-341X.1999.00971.x

By:

Stallard, Nigel;
Thall, Peter F.;
Whitehead, John

Publication type:

Article

Time to platelet recovery predicts outcome of patients with de novo acute lymphoblastic leukaemia who have achieved a complete remission.

Published in:

British Journal of Haematology, 2002, v. 117, n. 4, p. 869, doi. 10.1046/j.1365-2141.2002.03506.x

By:

Faderl, Stefan;
Thall, Peter F;
Kantarjian, Hagop M;
Estrov, Zeev

Publication type:

Article

Employing the treatment-free interval of intermittent androgen ablation to screen candidate prostate cancer therapies.

Published in:

Prostate, 2007, v. 67, n. 15, p. 1677, doi. 10.1002/pros.20649

By:

Mao, Shifeng;
Daliani, Danai D.;
Wang, Xuemei;
Thall, Peter F.;
Do, Kim-Anh;
Perez, Cherie A.;
Brown, Melissa A.;
Bouchillon, Kathleen;
Carter, Cindy M.;
Logothetis, Christopher J.;
Kim, Jeri

Publication type:

Article

Discussion on “A Hybrid Selection and Testing Procedure with Curtailment for Comparative Clinical Trials” by Elena M. Buzaianu and Pinyuen Chen.

Published in:

Sequential Analysis, 2009, v. 28, n. 1, p. 41, doi. 10.1080/07474940802619170

By:

Thall, Peter F.

Publication type:

Article

Clinical trial design as a decision problem.

Published in:

Applied Stochastic Models in Business & Industry, 2017, v. 33, n. 3, p. 296, doi. 10.1002/asmb.2222

By:

Müller, Peter;
Xu, Yanxun;
Thall, Peter F.

Publication type:

Article

Adverse Event Burden Score—A Versatile Summary Measure for Cancer Clinical Trials.

Published in:

Cancers, 2020, v. 12, n. 11, p. 3251, doi. 10.3390/cancers12113251

By:

Le-Rademacher, Jennifer G.;
Hillman, Shauna;
Storrick, Elizabeth;
Mahoney, Michelle R.;
Thall, Peter F.;
Jatoi, Aminah;
Mandrekar, Sumithra J.

Publication type:

Article

Utility-based designs for randomized comparative trials with categorical outcomes.

Published in:

2016

By:

Murray, Thomas A.;
Thall, Peter F.;
Yuan, Ying

Publication type:

journal article

Optimization of multi-stage dynamic treatment regimes utilizing accumulated data.

Published in:

2015

By:

Huang, Xuelin;
Choi, Sangbum;
Wang, Lu;
Thall, Peter F.

Publication type:

journal article

Defining and ranking effects of individual agents based on survival times of cancer patients treated with combination chemotherapies.

Published in:

Statistics in Medicine, 2011, v. 30, n. 15, p. 1777, doi. 10.1002/sim.4249

By:

Thall, Peter F.;
Liu, Diane D.;
Berrak, Su G.;
Wolff, Johannes E.

Publication type:

Article

A Bayesian feature allocation model for identifying cell subpopulations using CyTOF data.

Published in:

Journal of the Royal Statistical Society: Series C (Applied Statistics), 2023, v. 72, n. 3, p. 718, doi. 10.1093/jrsssc/qlad029

By:

Lui, Arthur;
Lee, Juhee;
Thall, Peter F;
Daher, May;
Rezvani, Katy;
Basar, Rafet

Publication type:

Article

Utility‐based Bayesian personalized treatment selection for advanced breast cancer.

Published in:

Journal of the Royal Statistical Society: Series C (Applied Statistics), 2022, v. 71, n. 5, p. 1605, doi. 10.1111/rssc.12582

By:

Lee, Juhee;
Thall, Peter F.;
Lim, Bora;
Msaouel, Pavlos

Publication type:

Article

Bayesian non‐parametric survival regression for optimizing precision dosing of intravenous busulfan in allogeneic stem cell transplantation.

Published in:

Journal of the Royal Statistical Society: Series C (Applied Statistics), 2019, v. 68, n. 3, p. 809, doi. 10.1111/rssc.12331

By:

Xu, Yanxun;
Thall, Peter F.;
Hua, William;
Andersson, Borje S.

Publication type:

Article

Optimizing natural killer cell doses for heterogeneous cancer patients on the basis of multiple event times.

Published in:

Journal of the Royal Statistical Society: Series C (Applied Statistics), 2019, v. 68, n. 2, p. 461, doi. 10.1111/rssc.12271

By:

Lee, Juhee;
Thall, Peter F.;
Rezvani, Katy

Publication type:

Article

Parametric dose standardization for optimizing two-agent combinations in a phase I-II trial with ordinal outcomes.

Published in:

Journal of the Royal Statistical Society: Series C (Applied Statistics), 2017, v. 66, n. 1, p. 201, doi. 10.1111/rssc.12162

By:

Thall, Peter F.;
Nguyen, Hoang Q.;
Zinner, Ralph G.

Publication type:

Article

Bayesian group sequential clinical trial design using total toxicity burden and progression-free survival.

Published in:

Journal of the Royal Statistical Society: Series C (Applied Statistics), 2016, v. 65, n. 2, p. 273, doi. 10.1111/rssc.12117

By:

Hobbs, Brian P.;
Thall, Peter F.;
Lin, Steven H.

Publication type:

Article

Bayesian treatment comparison using parametric mixture priors computed from elicited histograms.

Published in:

2019

By:

Thall, Peter F.;
Ursino, Moreno;
Baudouin, Véronique;
Alberti, Corinne;
Zohar, Sarah

Publication type:

journal article

Ethical issues in oncology biostatistics.

Published in:

2002

By:

Thall, Peter F

Publication type:

journal article

Bayesian adaptive model selection for optimizing group sequential clinical trials.

Published in:

Statistics in Medicine, 2008, v. 27, n. 27, p. 5586, doi. 10.1002/sim.3381

By:

Wathen, J. Kyle;
Thall, Peter F.

Publication type:

Article

Accounting for patient heterogeneity in phase II clinical trials.

Published in:

Statistics in Medicine, 2008, v. 27, n. 15, p. 2802, doi. 10.1002/sim.3109

By:

Wathen, J. Kyle;
Thall, Peter F.;
Cook, John D.;
Estey, Elihu H.

Publication type:

Article

Bayesian and frequentist two-stage treatment strategies based on sequential failure times subject to interval censoring.

Published in:

Statistics in Medicine, 2007, v. 26, n. 26, p. 4687, doi. 10.1002/sim.2894

By:

Thall, Peter F.;
Wooten, Leiko H.;
Logothetis, Christopher J.;
Millikan, Randall E.;
Tannir, Nizar M.

Publication type:

Article

Continuous Bayesian adaptive randomization based on event times with covariates.

Published in:

Statistics in Medicine, 2006, v. 25, n. 1, p. 55, doi. 10.1002/sim.2247

By:

Cheung, Ying Kuen;
Inoue, Lurdes Y. T.;
Wathen, J. Kyle;
Thall, Peter F.

Publication type:

Article

Covariate-adjusted adaptive randomization in a sarcoma trial with multi-stage treatments.

Published in:

Statistics in Medicine, 2005, v. 24, n. 13, p. 1947, doi. 10.1002/sim.2077

By:

Thall, Peter F.;
Wathen, J. Kyle

Publication type:

Article

Hierarchical Bayesian approaches to phase II trials in diseases with multiple subtypes.

Published in:

Statistics in Medicine, 2003, v. 22, n. 5, p. 763, doi. 10.1002/sim.1399

By:

Thall, Peter F.;
Wathen, J. Kyle;
Bekele, B. Nebiyou;
Champlin, Richard E.;
Baker, Laurence H.;
Benjamin, Robert S.

Publication type:

Article

Optimal two-stage designs for clinical trials based on safety and efficacy.

Published in:

Statistics in Medicine, 2001, v. 20, n. 7, p. 1023, doi. 10.1002/sim.717

By:

Thall, Peter F.;
Cheng, Su-Chun

Publication type:

Article

Evaluating multiple treatment courses in clinical trials.

Published in:

2000

By:

Thall, Peter F.;
Millikan, Randall E.;
Sung, Hsi-Guang;
Thall, P F;
Millikan, R E;
Sung, H G

Publication type:

journal article

Accrual strategies for phase I trials with delayed patient outcome.

Published in:

1999

By:

Thall, Peter F.;
Jack Lee, J.;
Tseng, Chi-Hong;
Estey, Elihu H.;
Thall, P F;
Lee, J J;
Tseng, C H;
Estey, E H

Publication type:

journal article